Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544462 · ClinicalTrials.gov registry record
ANXA5 M2 Haplotyping in IVF Patients and Embryos
A clinical trial of Infertility and Pregnancy Complications, sponsored by Genomic Prediction.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04544462 is a study of Infertility and Pregnancy Complications that is active but no longer recruiting, run by Genomic Prediction. The registered enrollment target is 500 participants, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04544462, a study of Infertility and Pregnancy Complications, is active but no longer recruiting, sponsored by Genomic Prediction.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to characterize the association between history of pregnancy complications and M2 carrier status in IVF patients and the utility of M2 haplotype preimplantation genetic testing (PGT) in embryos produced by carrier couples. Participants in this study will be screened for the M2 variant. History of pregnancy complications and miscarriages will be studied in order to determine potential associations with M2 carrier-ship.
Conditions Studied
Interventions
- OTHER M2 Test
Study Locations (1)
New Jersey
- Genomic Prediction Clinical Laboratory - North Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04544462
The ClinicalTrials.gov registry entry for NCT04544462 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower). The listed sponsor is Genomic Prediction, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which M2 Test is the first listed.
NCT04544462 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT04544462 about?
NCT04544462 is a clinical study titled "ANXA5 M2 Haplotyping in IVF Patients and Embryos". This study aims to characterize the association between history of pregnancy complications and M2 carrier status in IVF patients and the utility of M2 haplotype preimplantation genetic testing (PGT) in embryos produced by carrier couples. Participants in this study will be screened for the M2 varian...
What is the current status of trial NCT04544462?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-02-10. Estimated completion is 2026-12.
What conditions does trial NCT04544462 study?
This clinical trial studies the following conditions: Infertility, Pregnancy Complications, Miscarriage, Recurrent.
What interventions are being tested in trial NCT04544462?
The interventions under investigation include: M2 Test (OTHER).
Who is sponsoring clinical trial NCT04544462?
This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04544462 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.